NCT00101335View on ClinicalTrials.gov

Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2003

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
Head and Neck CancerPrecancerous Condition
Interventions
DRUG

celecoxib

Trial Locations (1)

19111-2497

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT00101335 - Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia | Biotech Hunter | Biotech Hunter